General procedure for the synthesis of compound 3 with
conventional heating
(d, J = 8.4 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) d 198.09,
1
162.43 (d, JC–F = 246.6 Hz), 162.33, 150.40, 148.81, 133.43 (d,
3
4JC–F = 3.7 Hz), 131.88, 129.93 (d, JC–F = 8.0 Hz, 2C), 128.73,
A mixture containing 2-aminoarylketone or 2-aminoarylaldehyde
1 (1 mmol), carbonyl compound 2 (1 mmol) and p-TsOH (1 mmol)
was introduced into a test tube (10 mL) and stirred at 100 ◦C
(oil bath temperature) for the designated time. When the reaction
was completed (monitored by TLC), the subsequent work-up
procedure was the same as that of the above microwave irradiation
conditions.
2
128.00, 127.60, 126.66, 124.09, 115.34 (d, JC–F = 21.7 Hz, 2C),
40.75, 34.69, 21.43; FT-IR (KBr) 3065, 2949, 1691, 1552, 1513,
1489, 1220, 1162, 852, 770, 540 cm−1; HRMS (+EI) calcd for
C19H14FNO (M+): 291.1059, found: 291.1057.
3,3-Dimethyl-9-(4-fluorophenyl)-1,2,3,4-tetrahydro-1-acridinone
(3h). 1H NMR (300 MHz, CDCl3) d 1.16 (s, 6H), 2.57 (s, 2H),
3.28 (s, 2H), 7.12–7.23 (m, 4H), 7.40–7.48 (m, 2H), 7.78 (ddd,
J = 8.3, 6.2, 2.2 Hz, 1H), 8.08 (d, J = 8.3 Hz, 1H); 13C NMR
(75.5 MHz, CDCl3) d 198.16, 162.48 (d, 1JC–F = 246.6 Hz), 161.29,
General procedure for the synthesis of compound 3 with microwave
irradiation in a monomodal EmrysTM Creator microwave
synthesizer
150.06, 149.19, 133.41 (d, 4JC–F = 3.5 Hz), 131.86, 129.98 (d, 3JC–F
=
7.9 Hz, 2C), 128.79, 128.09, 127.58, 126.73, 123.00, 115.40 (d,
2JC–F = 21.7 Hz, 2C), 54.40, 48.52, 32.36, 28.4 (2C); FT-IR (KBr)
3063, 2958, 1686, 1556, 1487, 1215, 777, 550 cm−1; HRMS (+EI)
calcd for C21H18FNO (M+): 319.1372, found: 319.1370.
All reactions were performed in a monomodal EmrysTM Cre-
ator from Personal Chemistry, Uppsala, Sweden. Typically,
in a 10 mL EmrysTM reaction vial, 2-aminoarylketone or 2-
aminoarylaldehyde 1 (1 mmol), carbonyl compound 2 (1 mmol)
and p-TsOH (1 mmol) were mixed and then capped. The mixture
was irradiated at 300 W or 150 W and at 100 ◦C for a given
time. The subsequent work-up procedure was the same as that in
a SANYO EM-350S microwave oven.
4-(4-Fluorophenyl)-2-phenylquinoline (3i). 1H NMR (300 MHz,
CDCl3) d 7.23–7.28 (m, 2H), 7.45–7.57 (m, 6H), 7.73–7.80 (m,
2H), 7.86 (d, J = 8.1 Hz, 1H), 8.19 (d, J = 6.7 Hz, 2H), 8.29 (d,
J = 7.0 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) d 163.07 (d,
1JC–F = 248.1 Hz), 157.03, 148.94, 148.26, 139.65, 134.49 (d,
1-[2-Methyl-4-(4-fluorophenyl)quinolin-3-yl]ethanone (3d). 1H
NMR (300 MHz, CDCl3) d 2.04 (s, 3H), 2.70 (s, 3H), 7.23 (tt,
J = 8.7, 2.1 Hz, 2H), 7.33–7.38 (m, 2H), 7.47 (ddd, J = 8.3, 6.8,
1.2 Hz, 1H), 7.58 (dd, J = 8.3, 1.2 Hz, 1H), 7.74 (ddd, J = 8.3,
6.8, 1.4 Hz, 1H), 8.08 (d, J = 8.3 Hz, 1H); 13C NMR (75.5 MHz,
3
4JC–F = 3.5 Hz), 131.40 (d, JC–F = 8.2 Hz, 2C), 130.34, 129.77,
129.57, 128.99 (2C), 127.72 (2C), 126.62, 125.89, 125.49, 119.53,
2
115.81 (d, JC–F = 21.6 Hz, 2C); FT-IR (KBr) 3053, 1608, 1492,
1224, 840, 764, 698 cm−1; HRMS (+EI) calcd for C21H14FN (M+):
299.1110, found: 299.1113.
1
CDCl3) d 205.56, 163.15 (d, JC–F = 249.6 Hz), 153.57, 147.66,
2-(4-Chlorophenyl)-4-(4-fluorophenyl)quinoline (3j). 1H NMR
(300 MHz, CDCl3) d 7.23–7.29 (m, 2H), 7.48–7.56 (m, 5H), 7.73–
7.78 (m, 2H), 7.86 (d, J = 8.4 Hz, 1H), 8.16 (d, J = 6.6 Hz, 2H),
8.22 (d, J = 8.5 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) d 163.13 (d,
1JC–F = 248.5 Hz), 155.68, 148.92, 148.51, 138.05, 135.83, 134.36
(d, 4JC–F = 3.5 Hz), 131.39 (d, 3JC–F = 8.2 Hz, 2C), 130.32, 129.95,
129.19 (2C), 128.97 (2C), 126.85, 125.96, 125.55, 119.08, 115.87
142.82, 135.19, 132.00 (d, 3JC–F = 8.2 Hz, 2C), 131.17 (d, 4JC–F
=
=
3.5 Hz), 130.28, 129.12, 126.79, 125.93, 125.15, 116.03 (d, 2JC–F
21.7 Hz, 2C), 32.11, 23.93; FT-IR (KBr) 3044, 1697, 1604, 1573,
1511, 1488, 1404, 1392, 1212, 1159, 1095, 858, 766 cm−1; HRMS
(+EI) calcd for C18H14FNO (M+): 279.1059, found: 279.1053.
9-(4-Fluorophenyl)-2,3-dihydro-1H-cyclopenta[b]quinoline (3e).
1H NMR (300 MHz, CDCl3) d 2.18 (quintet, J = 7.5 Hz, 2H), 2.90
(t, J = 7.4 Hz, 2H), 3.24 (t, J = 7.6 Hz, 2H), 7.19–7.27 (m, 2H),
7.32–7.42 (m, 3H), 7.58–7.66 (m, 2H), 8.07 (d, J = 7.9 Hz, 1H);
13C NMR (75.5 MHz, CDCl3) d 167.53, 162.64 (d, 1JC–F = 247.4
Hz), 148.09, 141.80, 133.94, 132.75 (d, 4JC–F = 3.7 Hz), 131.15 (d,
3JC–F = 8.1 Hz, 2C), 129.04, 128.44, 126.34, 125.76, 125.46, 115.74
(d, 2JC–F = 21.5 Hz, 2C), 35.30, 30.44, 23.62; FT-IR (KBr) 3064,
2959, 1607, 1495, 1382, 1221, 1159, 840, 764, 562 cm−1; HRMS
(+EI) calcd for C18H14FN (M+): 263.1110, found: 263.1101.
2
(d, JC–F = 21.6 Hz, 2C); FT-IR (KBr) 3068, 1604, 1492, 1224,
1091, 832, 760 cm−1; HRMS (+EI) calcd for C21H1335ClFN (M+):
333.0721, found: 333.0719.
3,3-Dimethyl-9-methyl-1,2,3,4-tetrahydro-1-acridinone (3p).
1H NMR (300 MHz, CDCl3) d 1.14 (s, 6H), 2.67 (s, 2H), 3.08 (s,
3H), 3.19 (s, 2H), 7.57 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.77 (ddd,
J = 8.4, 6.9, 1.4 Hz, 1H), 8.01 (d, J = 8.4 Hz, 1H), 8.22 (d, J =
8.4 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) d 200.32, 160.94,
149.56, 148.12, 131.33, 129.09, 127.55, 126.28, 125.41, 124.05,
54.74, 48.43, 31.97, 28.20 (2C), 15.81; FT-IR (KBr) 2955, 2968,
1682, 1560,1494, 1373, 1280, 1215, 762 cm−1; HRMS (+EI) calcd
for C16H17NO (M+): 239.1310, found: 239.1308.
9-(4-Fluorophenyl)-1,2,3,4-tetrahydroacridine (3f). 1H NMR
(300 MHz, CDCl3) d 1.76–1.84 (m, 2H), 1.93–2.01 (m, 2H), 2.59 (t,
J = 6.4 Hz, 2H), 3.20 (t, J = 6.6 Hz, 2H), 7.21–7.36 (m, 6H), 7.61
(ddd, J = 8.4, 6.2, 2.1 Hz, 1H), 8.02 (d, J = 8.4 Hz, 1H); 13C NMR
(75.5 MHz, CDCl3) d 162.54 (d, 1JC–F = 246.9 Hz), 159.26, 146.43,
145.65, 133.06 (d, 4JC–F = 3.7 Hz), 131.00 (d, 3JC–F = 7.9 Hz, 2C),
Ethyl 6,8-dibromo-2-methyl-3-quinolinecarboxylate (3q). 1H
NMR (300 MHz, CDCl3) d 1.46 (t, J = 7.1 Hz, 3H), 3.03 (s,
3H), 4.45 (q, J = 7.1 Hz, 2H), 8.00 (t, J = 2.0 Hz, 1H), 8.20
(d, J = 2.0 Hz, 1H), 8.62 (s, 1H); 13C NMR (75.5 MHz, CDCl3)
d 165.66, 160.01, 144.14, 138.98, 137.48, 130.06, 127.42, 125.42,
125.27, 119.47, 61.77, 26.96, 14.35; FT-IR (KBr) 3075, 2989, 1709,
1601, 1582, 1284, 1254, 1068, 870, 786 cm−1; HRMS (+EI) calcd
for C13H1179Br2NO2 (M+): 370.9157, found: 370.9162.
128.80, 128.60, 128.58, 126.87, 125.70, 125.66, 115.87 (d, 2JC–F
=
21.4 Hz, 2C), 34.33, 28.21, 23.14, 23.00; FT-IR (KBr) 3058, 2930,
2860, 1603, 1512, 1491, 1218, 1156, 847, 758, 564 cm−1; HRMS
(+EI) calcd for C19H16FN (M+): 277.1267, found: 277.1261.
9-(4-Fluorophenyl)-1,2,3,4-tetrahydro-1-acridinone (3g). 1H
NMR (300 MHz, CDCl3) d 2.26 (quintet, J = 6.5 Hz, 2H), 2.71
(t, J = 6.6 Hz, 2H), 3.38 (t, J = 6.3 Hz, 2H), 7.14–7.23 (m, 4H),
7.42–7.44 (m, 2H), 7.78 (ddd, J = 8.4, 6.2, 2.2 Hz, 1H), 8.07
1
1-(6,8-Dibromo-2-methylquinolin-3-yl)ethanone (3r). H NMR
(300 MHz, CDCl3) d 2.71 (s, 3H), 2.93 (s, 3H), 7.97 (d, J = 2.1 Hz,
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 104–110 | 1 0 9
©